NEFL and neuropathy: We investigated whether there are differences in NfL levels in the patients with ongoing BTZ treatment compared to those who have completed their BTZ treatment and to healthy controls, and whether NfL levels would correlate to measures of axonal damage and severity of the neuropathy.